According to Anixa Biosciences's latest financial reports the company has $23.6 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-10-31 | $23.37 M | -17.12% |
2022-10-31 | $28.2 M | -18.89% |
2021-10-31 | $34.76 M | 320.69% |
2020-10-31 | $8.26 M | 71.73% |
2019-10-31 | $4.81 M | -7.16% |
2018-10-31 | $5.18 M | -34.58% |
2017-10-31 | $7.92 M | 702.34% |
2016-10-31 | $0.98 M | -80.46% |
2015-10-31 | $5.05 M | 26.04% |
2014-10-31 | $4 M | -220.75% |
2013-10-31 | $-3.33 M | 178.09% |
2012-10-31 | $-1.2 M | -212.86% |
2011-10-31 | $1.05 M | -76.98% |
2010-10-31 | $4.59 M | 3.23% |
2009-10-31 | $4.45 M | 157.32% |
2008-10-31 | $1.73 M | 45.24% |
2007-10-31 | $1.19 M | -7.06% |
2006-10-31 | $1.28 M | 14.65% |
2005-10-31 | $1.11 M | -40.31% |
2004-10-31 | $1.87 M | -5.8% |
2003-10-31 | $1.98 M | -14.21% |
2002-10-31 | $2.31 M | -44.38% |
2001-10-31 | $4.16 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.22 B | 849.36% | ๐บ๐ธ USA |